Skip to content

VHT · ARCA · ETF

Vanguard Health Care ETF (VHT) Price, Holdings & Fees

$334.24−0.84%−$2.82End-of-day price as of Oct 9, 2026

Vanguard Health Care ETF (VHT) closed at $334.24 on Oct 9, 2026, down 0.84% from the previous close of $337.06.

Share price, past year

1Y +15.97%

52-week range $266.14 – $351.34. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$334.24
Sep 30, 2026$328.08
Aug 31, 2026$341.51
Jul 31, 2026$338.54
Jun 30, 2026$326.25
May 29, 2026$320.95
Apr 30, 2026$305.54
Mar 31, 2026$284.82
Feb 27, 2026$291.31
Jan 30, 2026$289.50
Dec 31, 2025$278.34
Nov 28, 2025$278.96
Oct 31, 2025$288.49

Key statistics

Expense ratio
0.09%
as of Aug 31, 2025
Net assets
$19B
as of May 31, 2026
Holdings
407
as of May 31, 2026
52-week range
$266.14 – $351.34

Vanguard Health Care ETF's expense ratio is 0.09%: $9.00 a year on $10,000 invested.

Holdings

Vanguard Health Care ETF held 407 investments worth $18.99B as of May 31, 2026. Its largest holding was Eli Lilly & Co, at 14.04% of the fund.

Vanguard Health Care ETF largest holdings by share of net assets
#Holding% of fundValue
1Eli Lilly & Co14.04%$2.67B
2Johnson & Johnson8.47%$1.61B
3AbbVie Inc6.09%$1.16B
4UnitedHealth Group Inc5.45%$1.03B
5Merck & Co Inc4.66%$885.00M
6Thermo Fisher Scientific Inc2.93%$555.74M
7Amgen Inc2.87%$544.66M
8Gilead Sciences Inc2.64%$500.92M
9Intuitive Surgical Inc2.38%$452.10M
10Pfizer Inc2.35%$447.04M
11Abbott Laboratories2.35%$447.02M
12Bristol-Myers Squibb Co1.84%$349.61M
13Danaher Corp1.84%$348.74M
14CVS Health Corp1.83%$346.91M
15Vertex Pharmaceuticals Inc1.80%$341.05M
16Stryker Corp1.66%$315.33M
17Medtronic PLC1.50%$284.14M
18McKesson Corp1.45%$275.20M
19Elevance Health Inc1.35%$256.81M
20Cigna Group/The1.17%$222.56M
21Boston Scientific Corp1.13%$215.12M
22Regeneron Pharmaceuticals Inc1.00%$190.73M
23HCA Healthcare Inc0.96%$181.61M
24Edwards Lifesciences Corp0.79%$150.72M
25Cencora Inc0.79%$149.07M

Top 25 of 407 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Vanguard Health Care ETF holdings by asset type
Asset type% of fund
Stocks99.80%
Cash and short-term investments0.22%
Vanguard Health Care ETF holdings by country, largest 1
Country% of fund
United States100.02%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, Vanguard Health Care ETF's total return was −5.03%, as reported to the SEC.

Vanguard Health Care ETF monthly total returns
MonthTotal return
May 31, 2026+2.65%
Apr 30, 20260.00%
Mar 31, 2026−7.47%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Vanguard Health Care ETF
Ticker
VHT
Exchange
ARCA
Fund type
ETF
Trust
VANGUARD WORLD FUND
SEC series ID
S000004450
SEC CIK
0000052848
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by VANGUARD WORLD FUND, the trust behind Vanguard Health Care ETF, and cover all of its funds.

Frequently asked questions

What is VHT's price?

Vanguard Health Care ETF (VHT) closed at $334.24 on Oct 9, 2026, down 0.84% from the previous close of $337.06.

What is VHT's expense ratio?

Vanguard Health Care ETF's expense ratio is 0.09%: $9.00 a year on $10,000 invested.

What does VHT hold?

Vanguard Health Care ETF held 407 investments worth $18.99B as of May 31, 2026. Its largest holding was Eli Lilly & Co, at 14.04% of the fund. Its five largest holdings were Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc, Merck & Co Inc.

How has VHT performed?

Over the 3 months to May 31, 2026, Vanguard Health Care ETF's total return was −5.03%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Aug 31, 2025. Prices are generated sample data for development. Data sources and disclosures